What is Hypervision Surgical?
Hypervision Surgical operates at the intersection of deep tech and clinical medicine. The company specializes in the development of intelligent surgical imaging systems designed to provide real-time, actionable data during complex procedures. By leveraging hyperspectral imaging, the platform offers surgeons a non-invasive method to visualize tissue characteristics that are otherwise invisible, thereby enhancing diagnostic accuracy and improving patient outcomes. As a spin-out from Kings College London, the company maintains a strong academic foundation while aggressively pursuing commercial scalability in the global surgical technology market.
How much funding has Hypervision Surgical raised?
Hypervision Surgical has raised a total of $30.7M across 2 funding rounds:
Angel/Seed
$7.8M
Series A
$22.9M
Angel/Seed (2023): $7.8M with participation from LifeX Ventures, Heran Partners, and Redalpine
Series A (2026): $22.9M led by LifeX Ventures, Redalpine, Angelini Ventures, Heran Partners, ZEISS, and SAGES Ingenuity
Key Investors in Hypervision Surgical
Redalpine
A thesis-driven venture capital firm established in 2006 that leverages a team of scientists and operators to provide hands-on strategic support to highly technical, disruptive companies.
Heran Partners
A Belgium-based investor focused on the healthcare and life sciences sectors, providing capital and mentorship to teams demonstrating strong scientific and entrepreneurial capabilities.
ZEISS
An international technology enterprise specializing in optics and medical technology, providing strategic industry expertise and infrastructure to support innovation in surgical imaging.
What's next for Hypervision Surgical?
With the successful closure of this Series A financing, Hypervision Surgical is poised to accelerate its clinical validation programs and expand its operational footprint. The strategic backing from industry leaders and specialized venture capital firms provides the necessary resources to transition from prototype development to widespread clinical adoption. Future growth initiatives will likely focus on regulatory milestones, the refinement of AI-driven diagnostic algorithms, and the integration of its imaging technology into existing surgical workflows, solidifying its role as a critical player in the next generation of intelligent operating rooms.
See full Hypervision Surgical company page
